(IN BRIEF) Nestlé has successfully divested its peanut allergy treatment business, Palforzia, to biopharmaceutical company Stallergenes Greer. This move follows…
(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis…
(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq:…
(PRESS RELEASE) VEVEY, Switzerland, 28-Jan-2020 — /EuropaWire/ — Nestlé, is in discussion with Allergan, a leading pharmaceutical company, to acquire…